(-0.08%) 5 465.07 points
(-0.08%) 39 079 points
(0.16%) 17 746 points
(-0.59%) $80.35
(-4.32%) $2.64
(-0.86%) $2 310.80
(-0.05%) $28.86
(2.30%) $1 009.10
(0.30%) $0.936
(0.73%) $10.68
(0.48%) $0.792
(-0.27%) $87.25
Quarter results tomorrow
(tns 2024-06-27)
Expected move: +/- 8.56%
Live Chart Being Loaded With Signals
Aceragen, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare pulmonary and rheumatic diseases in the United States...
Stats | |
---|---|
Today's Volume | 52 509 |
Average Volume | 92 008 |
Market Cap | 3.24M |
EPS | $0 ( Q1 | 2023-03-31 ) |
Next earnings date | ( $0 ) 2024-06-27 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-0.0448 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.131 (34.47%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-05-17 | Pillar Invest Corp | Buy | 26 965 | Common Stock |
2023-07-12 | Pillar Invest Corp | Sell | 3 605 | Common Stock |
2023-07-13 | Pillar Invest Corp | Sell | 2 213 | Common Stock |
2023-05-16 | Pillar Invest Corp | Buy | 0 | Common Stock |
2023-05-16 | Pillar Invest Corp | Buy | 0 | Common Stock |
INSIDER POWER |
---|
59.86 |
Last 3 transactions |
Buy: 26 965 | Sell: 5 818 |
Volume Correlation
Aceragen, Inc. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Aceragen, Inc. Correlation - Currency/Commodity
Aceragen, Inc. Financials
Annual | 2022 |
Revenue: | $4.86M |
Gross Profit: | $4.86M (100.00 %) |
EPS: | $-7.17 |
FY | 2022 |
Revenue: | $4.86M |
Gross Profit: | $4.86M (100.00 %) |
EPS: | $-7.17 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Aceragen, Inc.
Aceragen, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare pulmonary and rheumatic diseases in the United States. Its clinical development pipeline includes ACG-701, which is in Phase 2 clinical trial for cystic fibrosis pulmonary exacerbations, as well as for melioidosis; and ACG-801 for farber disease. Aceragen, Inc. has a collaboration and option agreement with Scriptr Global, Inc. to identify, research, and develop gene therapy candidates for the treatment, palliation, diagnosis, or prevention of myotonic dystrophy type 1 and Friedreich\'s Ataxia. The company was formerly known as Idera Pharmaceuticals, Inc. and changed its name to Aceragen, Inc. in January 2023. Aceragen, Inc. was incorporated in 1989 and is headquartered in Exton, Pennsylvania.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators